Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anthracycline Associated Disturbances of Cardiovascular Homeostasis
Ashot Avagimyan, L. V. Kakturskiy, Kiyan Heshmat‐Ghahdarijani, et al.
Current Problems in Cardiology (2021) Vol. 47, Iss. 5, pp. 100909-100909
Closed Access | Times Cited: 24

Showing 24 citing articles:

The Pathophysiological Basis of Diabetic Cardiomyopathy Development
Ashot Avagimyan, С. В. Попов, S. А. Shalnova
Current Problems in Cardiology (2022) Vol. 47, Iss. 9, pp. 101156-101156
Closed Access | Times Cited: 53
Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy
Ashot Avagimyan, Mohammad Sheibani, Nana Pogosova, et al.
International Journal of Cardiology (2023) Vol. 391, pp. 131331-131331
Closed Access | Times Cited: 13
Hyperoside prevents doxorubicin‐induced cardiotoxicity by inhibiting NOXs/ROS/NLRP3 inflammasome signaling pathway
Shanshan Wei, Wanjun Ma, Chuanhao Jiang, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 4196-4209
Closed Access | Times Cited: 12
Two-dimensional speckle tracking imaging and tissue Doppler imaging can predict subclinical left ventricular systolic and diastolic dysfunctions after chemotherapy for breast cancer
Haifei Niu, Zijian Ma, Shaoshi Yang, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1087-1096
Closed Access
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2025) Vol. 10, Iss. 1, pp. 101-109
Open Access
Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity
Nikša Drinković, Maja Beus, Rinea Barbir, et al.
Nanoscale (2024) Vol. 16, Iss. 19, pp. 9412-9425
Closed Access | Times Cited: 3
AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study
Ashot Avagimyan, Lusine Mkrtchyan, Orest Abrahomovich, et al.
Current Problems in Cardiology (2021) Vol. 47, Iss. 9, pp. 100994-100994
Closed Access | Times Cited: 15
Doxycycline Attenuates Doxorubicin-Induced Cardiotoxicity by Improving Myocardial Energy Metabolism in Rats
Danielle Dantas, Amanda Gomes Pereira, Anderson Seiji Soares Fujimori, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 8, pp. 254-254
Open Access | Times Cited: 11
Chemotherapy as a possible trigger for the myocardial lipomatosis development
Ashot Avagimyan, Lusine Mkrtchyan, Н. Б. Конончук, et al.
Arterial’naya Gipertenziya (Arterial Hypertension) (2022) Vol. 27, Iss. 6, pp. 706-712
Open Access | Times Cited: 10
Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case
Ashot Avagimyan, Lusine Mkrtchyan, Astkhik Artavazdovna Gevorkyan, et al.
Rational Pharmacotherapy in Cardiology (2021) Vol. 17, Iss. 5, pp. 785-791
Open Access | Times Cited: 14
Hyperhomocysteinemia as a Link of Chemotherapy-Related Endothelium Impairment
Ashot Avagimyan
Current Problems in Cardiology (2021) Vol. 47, Iss. 10, pp. 100932-100932
Closed Access | Times Cited: 13
Melatonin mitigates oxidative damage induced by anthracycline: a systematic-review and meta-analysis of murine models
Andrea Faggiano, Elisa Gherbesi, Ashot Avagimyan, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 5
DOXORUBICIN AND CYCLOPHOSPHAMIDE MODE OF CHEMOTHERAPY–RELATED CARDIOMYOPATHY: REVIEW OF PRECLINICAL MODEL
Ashot Avagimyan, L. V. Kakturskiy, Nana Pogosova, et al.
Current Problems in Cardiology (2024), pp. 102882-102882
Closed Access | Times Cited: 1
Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity
Ashot Avagimyan, А. И. Трофименко, Mohammad Sheibani, et al.
Innovative medicine of Kuban (2023), Iss. 4, pp. 6-14
Open Access | Times Cited: 3
Diabefit as a Modifier of Fructose-induced Impairment of Cardio-vascular System
Ashot Avagimyan, Lilit Sukiasyan, L. V. Kakturskiy, et al.
Current Problems in Cardiology (2021) Vol. 47, Iss. 10, pp. 100943-100943
Closed Access | Times Cited: 6
Trimetazidine as a modifier of doxorubicin+cyclophosphamideinduced hyperdyslipidemia
Ashot Avagimyan, L. V. Kakturskiy
Siberian Journal of Clinical and Experimental Medicine (2022) Vol. 37, Iss. 2, pp. 105-111
Open Access | Times Cited: 4
Trimetazidine as a Modifier of Chemotherapy-Induced Endothelium Homeostasis Disturbances
А.А. Авагимян, Л.В. Кактурский
Кардиология в Беларуси (2022), Iss. 3, pp. 263-272
Open Access | Times Cited: 4
Fructose-Induced Alteration of the Heart and Vessels Homeostasis
Lilit Sukiasyan
Current Problems in Cardiology (2021) Vol. 48, Iss. 2, pp. 101013-101013
Closed Access | Times Cited: 5
Chemotherapy, hypothyroidism and oral dysbiosis as a novel risk factor of cardiovascular pathology development
Ashot Avagimyan, Tamuna Gvianishvili, L Gogiashvili, et al.
Current Problems in Cardiology (2021) Vol. 48, Iss. 3, pp. 101051-101051
Closed Access | Times Cited: 5
CARDIOTOXICITY OF CYCLOPHOSPHAMIDE: CURRENT STATE OF THE PROBLEM
Ashot Avagimyan, L. V. Kaktursky
EXPERIMENTAL & CLINICAL MEDICINE GEORGIA (2022)
Open Access | Times Cited: 3
Trimetazidine as a Modifier of Chemotherapy-Induced Cardiovascular Redox-Homeostasis Disturbances
А.А. Авагимян, К. Хешмат-Гахдарижани, Л.В. Кактурский
Кардиология в Беларуси (2022), Iss. 4, pp. 404-411
Open Access | Times Cited: 3
Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis.
Ashot Avagimyan, Lusine Mkrtchyan, Tamara Bairamyan, et al.
PubMed (2024) Vol. 19, Iss. 5, pp. 52-62
Closed Access
Influence of trimetazidine on myocardium energy balance during chemotherapy with doxorubicin and cyclophosphamide
Ashot Avagimyan
Сибирский научный медицинский журнал (2022) Vol. 42, Iss. 3, pp. 41-46
Open Access | Times Cited: 2
Perivascular Adipose Tissue – Orchestrator of Cardiovascular Disturbances Sequel.
Artashes Aznauryan, Grizelda Navasardyan, Ashot Avagimyan
THE NEW ARMENIAN MEDICAL JOURNAL (2022), Iss. 4, pp. 107-114
Open Access | Times Cited: 2
Page 1

Scroll to top